Asia & Oceania Cannabis Industry & Marijuana Business News


New Zealand cannabis firm Helius raises NZ$20M for expansion, clinical trials

Weeks before New Zealand’s medical marijuana regulations take effect, Auckland-based Helius Therapeutics says it has raised 20 million New Zealand dollars ($12.8 million) to help fund facility expansion and clinical trials. Helius is among nearly two dozen companies that are licensed to grow cannabis for research purposes. After the regulatory foundation for New Zealand’s medical […]

Read More

Australia looks to implement single medical cannabis license for producers

The Australian government held public consultations on a proposal to implement a single medical cannabis license for producers, which experts say would address lengthy delays and disproportionate levels of paperwork facing businesses. The proposal is part of a government-commissioned report written in 2019 by John McMillan – a law professor at Australian National University in […]

Read More

Australia expedites review of medical cannabis product Epidiolex

The only medical cannabis product in the Australian Register of Therapeutic Goods might soon be joined by another. Australian health regulators quietly gave Epidiolex, a cannabidiol medication, orphan designation and priority review status in late 2019. The designations allow the Therapeutic Goods Administration to waive application and evaluation fees, as well as expedite its assessment […]

Read More

Australia to wrap up CBD review by March

Australian health authorities expect to conclude their safety review of cannabidiol in low doses in March, the results of which could inform any decision to down-schedule the popular cannabinoid. Any move to reschedule certain doses of CBD, making it available over the counter, could open the door to new market opportunities for businesses. The Therapeutic […]

Read More

Australia says over-the-counter CBD sales ‘could be considered during 2020’

A review of cannabidiol products being undertaken by Australian health authorities could result in the relaxation of the scheduling status of CBD, potentially making it available over the counter in low doses. In a public submission to a Senate committee studying Australia’s medical cannabis access scheme, the Department of Health said the Therapeutic Goods Administration […]

Read More

Former Roche executive takes helm of New Zealand cannabis firm Rua Bioscience

Longtime Roche executive Rob Mitchell is taking the reins of New Zealand medical cannabis firm Rua Bioscience, replacing co-founder Manu Caddie as CEO. Mitchell spent most of his career heading global product strategy for Roche, a multinational health-care company. Caddie, who founded Hikurangi Cannabis Company (renamed Rua Bioscience) in 2016, will continue to lead the company’s […]

Read More

New Zealand’s adult-use cannabis referendum is set for September

New Zealand has scheduled a date for its next general election, which will coincide with a referendum on the legalization of recreational cannabis. On Sept. 19, New Zealanders will be asked to answer the straightforward question, “Do you support the proposed Cannabis Legalization and Control Bill?” Two options will be on the ballot: “Yes, I […]

Read More

Realistic expectations for New Zealand’s cannabis market: Q&A with Rua Bioscience CEO Manu Caddie

With the launch of New Zealand’s medical cannabis program two months away and a referendum to legalize adult-use marijuana slated for later this year, businesses from around the world already have their sights set on the Oceanic market. New Zealand’s Medicinal Cannabis Agency will become operational April 1, when regulations laying the industry’s regulatory foundation […]

Read More

Report: Thailand issues 442 medical cannabis licenses, but full market access years away

Thailand is on track to be competitive in the nascent Asian medical marijuana and hemp markets, but the full commercialization of the sector and liberal access for private businesses is not likely to be implemented before 2024, according to a new report. The country’s medical cannabis market is characterized by high potential, fast regulatory developments […]

Read More

New Zealand to overturn cannabis vaporizer ban, clearing the way for imports

New Zealand plans to reverse a law banning cannabis vaporizers before new regulations kick in for the launch of the country’s medical program in April, Marijuana Business Daily has learned. “Currently, vaporizers are prohibited under the Misuse of Drugs (Prohibition of Cannabis Utensils and Methamphetamine Utensils) Notice,” a Health Ministry spokesperson told MJBizDaily. The “cabinet has […]

Read More

European Commission proposes unified EU vote on WHO cannabis scheduling recommendations

In advance of the March session of the United Nations Commission on Narcotic Drugs (CND), the European Union’s executive branch has proposed that EU member nations vote in favor of three of the six World Health Organization (WHO) cannabis scheduling recommendations. The European Commission “Proposal for a Council Decision” is meaningful because – if adopted by […]

Read More